Apoptosis of Mature B Cells

References

• Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996; 381: 751–8
   PubMed Web of Science ®Google Scholar
• Lam K. P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997; 90: 1073–83
   PubMed Web of Science ®Google Scholar
• Wienands J., Larbolette O., Reth M. Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc. Natl. Acad. Sci. USA 1996; 93: 7865–70
   PubMedGoogle Scholar
• Nakayama K., Nakayama K., Negishi I., Kuida K., Sawa H., Loh D. Y. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 1994; 91: 3700–4
   PubMed Web of Science ®Google Scholar
• Nakayama K., Nakayama K., Negishi I., Kuida K., Shinkai Y., Louie M. C., Fields L. E., Lucas P. J., Stewart V., Alt F. W. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993; 261: 1584–8
   PubMed Web of Science ®Google Scholar
• Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229–40
   PubMed Web of Science ®Google Scholar
• Nunez G., Merino R., Grillot D., Gonzalez G. M. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today 1994; 15: 582–8
   PubMedGoogle Scholar
• Kantor A. B., Herzenberg L. A. Origin of murine B cell lineages. Annu. Rev. Immunol. 1993; 11: 501–38
   PubMed Web of Science ®Google Scholar
• Murakami M., Tsubata T., Okamoto M., Shimizu A., Kumagai S., Imura H., Honjo T. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357: 77–80
   PubMed Web of Science ®Google Scholar
• Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 1992; 175: 71–9
   PubMed Web of Science ®Google Scholar
• Nemazee D., Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989; 337: 562–6
   PubMed Web of Science ®Google Scholar
• Hartley S. B., Crosbie J., Brink R., Kantor A. B., Basten A., Goodnow C. C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991; 353: 765–9
   PubMed Web of Science ®Google Scholar
• Tsubata T., Murakami M., Honjo T. Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice. Curr. Biol. 1994; 4: 8–17
   PubMed Web of Science ®Google Scholar
• Lang J., Arnold B., Hammerling G., Harris A. W., Korsmeyer S., Rusell D., Strasser A., Nemazee D. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive immature B cells. J. Exp. Med. 1997; 186: 1513–22
   PubMed Web of Science ®Google Scholar
• Parry S. L., Hasbold J., Holman M., Klaus G. G. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 1994; 152: 2821–9
   PubMed Web of Science ®Google Scholar
• Parry S. L., Holman M. J., Hasbold J., Klaus G. G. Plastic-immobilized antimu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 1994; 24: 974–9
   PubMed Web of Science ®Google Scholar
• Chaouchi N., Vazquez A., Galanaud P., Leprince C. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J. Immunol. 1995; 154: 3096–104
   PubMed Web of Science ®Google Scholar
• Fulcher D. A., Lyons A. B., Korn S. L., Cook M. C., Koleda C., Parish C., Fazekas D. S., Groth B., Basten A. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 1996; 183: 2313–28
   PubMed Web of Science ®Google Scholar
• Brunswick M., Finkelman F. D., Highet P. F., Inman J. K., Dintzis H. M. Picogram quantities of anti-Ig antibodies coupled to. J. Immunol. 1988; 140: 3364–72
   PubMed Web of Science ®Google Scholar
• Snapper C. M., Mc T. M., IntyreMandler R., Pecanha L. M., Finkelman F. D., Lees A. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent type 2 antigens. J. Exp. Med. 1992; 175: 1367–71
   PubMed Web of Science ®Google Scholar
• Pure E., Vitetta E. Induction of murine B cell proliferation by insolubilized anti-immunoglobulins. J. Immunol. 1980; 125: 1240–2
   Google Scholar
• Parker D. C. Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature 1975; 258: 361–3
   PubMedGoogle Scholar
• Finkelman F. D., Holmes J. M., Dukhanina O. I., Morris S. C. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 1995; 181: 515–25
   Google Scholar
• Fulcher D. A., Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 1994; 179: 125–34
   PubMedGoogle Scholar
• Tighe H., Warnatz K., Brinson D., Corr M., Weigle W. O., Baird S. M., Carson D. A. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc. Natl. Acad. Sci. USA 1997; 94: 646–51
   PubMed Web of Science ®Google Scholar
• Kozono Y., Kotzin B. L., Holers V. M. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J. Immunol. 1996; 156: 4498–503
   PubMed Web of Science ®Google Scholar
• Parker D. C. Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti-IgD on murine B cells. Immunol. Rev. 1980; 52: 115–39
   PubMedGoogle Scholar
• Udhayakumar V., Kumar L., Subbarao B. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. J. Immunol. 1991; 146: 4120–9
   Google Scholar
• Anderson J. S., Teutsch M., Dong Z., Wortis H. H. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 1996; 93: 10966–71
   PubMed Web of Science ®Google Scholar
• Choi M. S., Holman M., Atkins C. J., Klaus G. G. Expression of blc-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 1996; 26: 676–82
   PubMed Web of Science ®Google Scholar
• Morris D. L., Rothstein T. L. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 1993; 177: 857–61
   PubMedGoogle Scholar
• Bikah G., Carey J., Ciallella J. R., Tarakhovsky A., Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996; 274: 1906–9
   PubMed Web of Science ®Google Scholar
• Pani G., Fischer K. D., Mlinaric R. I., Siminovitch K. A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTPIC tyrosine phosphatase. J. Exp. Med. 1996; 184: 839–52
   PubMedGoogle Scholar
• Cyster J. G., Goodnow C. C. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 1997; 6: 509–17
   PubMed Web of Science ®Google Scholar
• Goodnow C. C., Cyster J. G., Hartley S. B., Bell S. E., Cooke M. P., Healy J. I., Akkaraju S., Rathmell J. C., Pogue S. L., Shokat K. P. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 1995; 59: 279–368
   PubMed Web of Science ®Google Scholar
• Carsetti R., Kohler G., Lamers M. C. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 1995; 181: 2129–40
   PubMed Web of Science ®Google Scholar
• Russell D. M., Dembic Z., Morahan G., Miller J. F., Burki K., Nemazee D. Peripheral deletion of self-reactive B cells. Nature 1991; 354: 308–11
   PubMed Web of Science ®Google Scholar
• Diamond B., Scharff M. D. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc. Natl. Acad. Sci. USA 1984; 81: 5841–4
   PubMed Web of Science ®Google Scholar
• Giusti A. M., Chien N. C., Zack D. J., Shin S. U., Scharff M. D. Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region. Proc. Natl. Acad. Sci. USA 1987; 84: 2926–30
   PubMed Web of Science ®Google Scholar
• Kelsoe G. In situ studies of the germinal center reaction. Adv. Immunol. 1995; 60: 267–88
   PubMed Web of Science ®Google Scholar
• Mac I., LennanCasamayor P. M., Toellner K. M., Gulbranson J. A., Gordon J. Memory B-cell clones and the diversity of their members. Sem. Immunol. 1997; 9: 229–34
   Google Scholar
• Pulendran B., Kannourakis G., Nouri S., Smith K. G., Nossal G. J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 1995; 375: 331–4
   PubMed Web of Science ®Google Scholar
• Shokat K. M., Goodnow C. C. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 1995; 375: 334–8
   PubMed Web of Science ®Google Scholar
• Nomura T., Han H., Howard M. C., Yagita H., Yakura H., Honjo T., Tsubata T. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice. Int. Immunol. 1996; 8: 867–75
   PubMed Web of Science ®Google Scholar
• Valentine M. A., Licciardi K. A. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur. J. Immunol. 1992; 22: 3141–8
   PubMed Web of Science ®Google Scholar
• Santos A. L., Gordon J., Heath A. W., Howard M. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Cell. Immunol. 1994; 156: 272–85
   Google Scholar
• Heath A. W., Wu W. W., Howard M. C. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 1994; 24: 828–34
   Google Scholar
• Lederman S., Yellin M. J., Cleary A. M., Pernis A., Inghirami G., Cohn L. E., Covey L. R., Lee J. J., Rothman P., Chess L. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 1994; 152: 2163–71
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Schrader J. W. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J. Immunol. 1981; 126: 2466–9
   PubMed Web of Science ®Google Scholar
• Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J. P., van Rousset K. C., Rousset Y. J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Johnson L. C., Hasbold J., Holman M., Klaus G. G. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice. J. Immunol. 1997; 159: 1150–9
   Google Scholar
• Genaro A. M., Gonzalo J. A., Bosca L., Martinez C. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression. Eur. J. Immunol. 1994; 24: 2515–21
   Google Scholar
• Choi M. S., Boise L. H., Gottschalk A. R., Quintans J., Thompson C. B., Klaus G. G. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 1995; 25: 1352–7
   PubMed Web of Science ®Google Scholar
• Ishida T., Kobayashi N., Tojo T., Ishida S., Yamamoto T., Inoue J. CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J. Immunol. 1995; 155: 5527–35
   PubMedGoogle Scholar
• Wang Z., Karras J. G., Howard R. G., Rothstein T. L. Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J. Immunol. 1995; 155: 3722–5
   PubMedGoogle Scholar
• Nisitani S., Tsubata T., Murakami M., Okamoto M., Honjo T. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 1993; 78: 1247–54
   Google Scholar
• Merino R., Grillot D. A., Simonian P. L., Muthukkumar S., Fanslow W. C., Bondada S., Nunez G. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 1995; 155: 3830–8
   PubMedGoogle Scholar
• Fang W., Rivard J. J., Ganser J. A., Le T. W., BienNath K. A., Mueller D. L., Behrens T. W. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 1995; 155: 66–75
   PubMed Web of Science ®Google Scholar
• Sonenshein G. E. Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion. J. Immunol. 1997; 158: 1994–7
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 1997; 6: 107–18
   PubMed Web of Science ®Google Scholar
• Kozono Y., Duke R. C., Schleicher M. S., Holers V. M. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur. J. Immunol. 1995; 25: 1013–7
   PubMed Web of Science ®Google Scholar
• Unkeless J. C., Jin J. Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immunol. 1997; 9: 338–43
   PubMedGoogle Scholar
• Adachi T., Flaswinkel H., Yakura H., Reth M., Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 1998; 160: 4662–5
   PubMed Web of Science ®Google Scholar
• Rothstein T. L., Wang J. K., Panka D. J., Foote L. C., Wang Z., Stanger B., Ju H., Ju S. T., Marshak R. A. Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374: 163–5
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Matsui K., Kashiwamura S., Nishioka Y., Nomura J., Nishimura Y., Sakaguchi N., Yonehara S., Higashino K., Shinka S. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. Int. Immunol. 1996; 8: 791–8
   PubMed Web of Science ®Google Scholar
• Garrone P., Neidhardt E. M., Garcia E. L., Galibert K. C., van Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 1995; 182: 1265–73
   PubMed Web of Science ®Google Scholar
• Schattner E. J., Elkon K. B., Yoo D. H., Tumang J., Krammer P. H., Crow M. K., Friedman S. M. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 1995; 182: 1557–65
   PubMed Web of Science ®Google Scholar
• Wang J., Taniuchi I., Maekawa Y., Howard M., Cooper M. D., Watanabe T. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 1996; 26: 92–6
   PubMed Web of Science ®Google Scholar
• Nagata S., Golstein P. The Fas death factor. Science 1995; 267: 1449–56
   PubMed Web of Science ®Google Scholar
• Yagita H., Hanabuchi S., Asano Y., Tamura T., Nariuchi H., Okumura K. Fas-mediated cytotoxicity - a new immunoregulatory and pathogenic function of Thl CD4+ T cells. Immunol. Rev. 1995; 146: 223–39
   Google Scholar
• Lagresle C., Mondiere P., Bella C., Krammer P. H., Defrance T. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 1996; 183: 1377–88
   PubMed Web of Science ®Google Scholar
• Foote L. C., Howard R. G., Marshak R. A., Rothstein T. L. IL-4 induces Fas resistance in B cells. J. Immunol. 1996; 157: 2749–53
   PubMed Web of Science ®Google Scholar
• Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969–76
   PubMed Web of Science ®Google Scholar
• Watanabe F. R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–7
   PubMed Web of Science ®Google Scholar
• Rieux L. F., Le D. F., Hivroz C., Roberts I. A., Debatin K. M., Fischer A., de Fischer V. J. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347–9
   PubMed Web of Science ®Google Scholar
• Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middleton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935–46
   PubMed Web of Science ®Google Scholar
• Rathmell J. C., Goodnow C. C. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 1994; 153: 2831–42
   PubMed Web of Science ®Google Scholar
• Rathmell J. C., Cooke M. P., Ho W. Y., Grein J., Townsend S. E., Davis M. M., Goodnow C. C. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995; 376: 181–4
   PubMed Web of Science ®Google Scholar
• Cooke M. P., Heath A. W., Shokat K. M., Zeng Y., Finkelman F. D., Linsley P. S., Howard M., Goodnow C. C. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 1994; 179: 425–38
   PubMed Web of Science ®Google Scholar
• Rathmell J. C., Townsend S. E., Xu J. C., Flavell R. A., Goodnow C. C. Expansion or elimination of B cells; in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996; 87: 319–29
   PubMed Web of Science ®Google Scholar
• Goodnow C. C., Brink R., Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature 1991; 352: 532–6
   PubMedGoogle Scholar
• Erikson J., Radic M. Z., Camper S. A., Hardy R. R., Carmack C., Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991; 349: 331–4
   PubMed Web of Science ®Google Scholar
• Strasser A., Whittingham S., Vaux D. L., Bath M. L., Adams J. M., Cory S., Harris A. W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 1991; 88: 8661–5
   PubMed Web of Science ®Google Scholar
• Spector M. S., Desnoyers S., Hoeppner D. J., Hengartner M. O. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 1997; 385: 653–6
   PubMedGoogle Scholar
• Kluck R. M., Bossy W. E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132–6
   PubMed Web of Science ®Google Scholar
• Strasser A., Harris A. W., Huang D. C., Krammer P. H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. Embo. J. 1995; 14: 6136–47
   PubMed Web of Science ®Google Scholar
• Desai M. A., Lu L., Ramsey G. R., Datta S. K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Inv. 1996; 97: 2063–73
   Google Scholar
• Koshy M., Berger D., Crow M. K. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Inv. 1996; 98: 826–37
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Eisenberg R. A. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 1992; 13: 427–8
   PubMedGoogle Scholar
• Nemazee D., Guiet C., Buerki K., Marshak R. A. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J. Immunol. 1991; 147: 2536–9
   PubMed Web of Science ®Google Scholar
• Hirose S., Yan K., Abe M., Jiang Y., Hamano Y., Tsurui H., Shirai T. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc. Natl. Acad. Sci. USA 1997; 94: 9291–5
   PubMed Web of Science ®Google Scholar
• Bignon J. S., Siminovitch K. A. Identification of PTPIC mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. & Immunopath. 1994; 73: 168–79
   PubMedGoogle Scholar
• Sato S., Miller A. S., Inaoki M., Bock C. B., Jansen P. J., Tang M. L., Tedder T. F. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 1996; 5: 551–62
   PubMed Web of Science ®Google Scholar
• Otipoby K. L., Andersson K. B., Draves K. E., Klaus S. J., Farr A. G., Kerner J. D., Perlmutter R. M., Law C. L., Clark E. A. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996; 384: 634–7
   PubMed Web of Science ®Google Scholar
• O'Keefe T. L., Williams G. T., Davies S. L., Neuberger M. S. Hyperresponsive B cells in CD22-deficient mice. Science 1996; 274: 798–801
   PubMed Web of Science ®Google Scholar
• Nitschke L., Carsetti R., Ocker B., Kohler G., Lamers M. C. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 1997; 7: 133–43
   PubMed Web of Science ®Google Scholar